Both in Pharmaceuticals
NRX Pharmaceuticals vs Unicycive Therapeutics
Over the past year NRXP returned −10.2% and UNCY returned +9.6%; their daily moves had a correlation of 0.07.
NRXP −10.2% UNCY +9.6%Growth of $1, one year, split-adjusted
| Metric | NRXP | UNCY |
|---|---|---|
| Price | $2.92 | $4.55 |
| Market cap | $126.4M | $126.7M |
| Today | +1.74% | −1.94% |
| 1 month | −17.7% | −13.6% |
| 6 months | +39.7% | −25.5% |
| Year to date | +7.7% | −21.1% |
| 1 year | −1.0% | +13.2% |
| Revenue growth (YoY) | — | — |
| Gross margin | 38.7% | — |
| Net margin | −1500.5% | — |
| P/E (TTM) | — | — |
| Price / sales | 37.2× | — |
| Net cash | $26.3M | $61.4M |
| Dividend yield | — | — |
| Volatility (60d) | 66.1% | 52.4% |
| Short % of float | 31.5% | 15.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).